Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Alcaraz A, Carballido-Rodríguez J, Unda-Urzaiz M, Medina-López R, Ruiz-Cerdá JL, Rodríguez-Rubio F, García-Rojo D, Brenes-Bermúdez FJ, Cózar-Olmo JM, Baena-González V, Manasanch J. Alcaraz A, et al. Int Urol Nephrol. 2016 May;48(5):645-56. doi: 10.1007/s11255-015-1206-7. Epub 2016 Jan 25. Int Urol Nephrol. 2016. PMID: 26810324 Free PMC article.
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Alcaraz A, Rodríguez-Antolín A, Carballido-Rodríguez J, Castro-Díaz D, Medina-Polo J, Fernández-Gómez JM, Ficarra V, Palou J, Ponce de León Roca J, Angulo JC, Esteban-Fuertes M, Cózar-Olmo JM, Pérez-León N, Molero-García JM, Fernández-Pro Ledesma A, Brenes-Bermúdez FJ, Manasanch J. Alcaraz A, et al. Among authors: carballido rodriguez j. Sci Rep. 2021 Sep 29;11(1):19401. doi: 10.1038/s41598-021-98586-5. Sci Rep. 2021. PMID: 34588509 Free PMC article.
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Alcaraz A, Rodríguez-Antolín A, Carballido-Rodríguez J, Castro-Díaz D, Esteban-Fuertes M, Cózar-Olmo JM, Ficarra V, Medina-López R, Fernández-Gómez JM, Angulo JC, Medina-Polo J, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Manasanch J, The Qualiprost Study Group OBO. Alcaraz A, et al. Among authors: carballido rodriguez j. J Clin Med. 2020 Sep 9;9(9):2909. doi: 10.3390/jcm9092909. J Clin Med. 2020. PMID: 32917008 Free PMC article.
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.
Alcaraz A, Gacci M, Ficarra V, Medina-Polo J, Salonia A, Fernández-Gómez JM, Ciudin A, Castro-Díaz D, Rodríguez-Antolín A, Carballido-Rodríguez J, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Ledesma AF, Herdman M, Manasanch J, Angulo JC, Group OBOTQS. Alcaraz A, et al. Among authors: carballido rodriguez j. J Clin Med. 2022 Feb 12;11(4):967. doi: 10.3390/jcm11040967. J Clin Med. 2022. PMID: 35207238 Free PMC article.
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.
Alcaraz A, Castro-Díaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodríguez J, Rodríguez-Antolín A, Medina-Polo J, Fernández-Gómez JM, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Herdman M, Angulo JC, Manasanch J, On Behalf Of The Qualiprost Study Group. Alcaraz A, et al. Among authors: carballido rodriguez j. J Clin Med. 2022 Jun 22;11(13):3615. doi: 10.3390/jcm11133615. J Clin Med. 2022. PMID: 35806900 Free PMC article.
Clinical drivers for imaging testing in non-metastatic castration-resistant prostate cancer in clinical practice: Results of the IDENTIFICA study.
Cózar Olmo JM, Carballido Rodríguez J, Rubio-Briones J, Useros Rodríguez E, Muñoz Del Toro J, García García-Porrero Á, Juárez-Soto Á; en nombre del grupo de investigadores del estudio IDENTIFICA. Cózar Olmo JM, et al. Among authors: carballido rodriguez j. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):198-206. doi: 10.1016/j.acuro.2020.12.001. Epub 2021 Feb 6. Actas Urol Esp (Engl Ed). 2021. PMID: 33558084 English, Spanish.
[Effectiveness and tolerability of zoledronic acid in the treatment of metastatic prostate cancer].
Cózar Olmo JM, Carballido Rodriguez J, Luque Galvez P, Tabernero Gómez AG, Barreiro Mouro A, Sánchez Sánchez E, González Enguita C, Alcover García J, Garcia-Galisteo E, Abascal García JM, Sanchez Chapado M, GómezVeiga F, Minguez Martínez RJ, Rodriguez Antolin A, Medina López RA, Rico Morales M, Regadera Sejas FJ, Búcar Terrades S, Jamardo Gonzalez D, Gálvez R. Cózar Olmo JM, et al. Actas Urol Esp. 2008 May;32(5):492-501. doi: 10.1016/s0210-4806(08)73873-7. Actas Urol Esp. 2008. PMID: 18604999 Clinical Trial. Spanish.
82 results